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Pancreas homeostasis is based on replication of differentiated cells in order to maintain proper organ size
and function under changing physiological demand. Recent studies suggest that acinar cells, themost abun-
dant cell type in the pancreas, are facultative progenitors capable of reverting to embryonic-like multipotent
progenitor cells under injury conditions associatedwith inflammation. In parallel, it is becoming apparent that
within the endocrine pancreas, hormone-producing cells can lose or switch their identity under metabolic
stress or in response to single gene mutations. This new view of pancreas dynamics suggests interesting
links between pancreas regeneration and pathologies including diabetes and pancreatic cancer.Facultative Progenitor Cells and Cellular
Reprogramming
The presence of adult pancreatic stem cells has been hotly
debated for many years. Numerous studies have suggested
that during adult life, new endocrine cells form by differentiation
of duct cells, budding to generate new islets. However, genetic
lineage tracing studies in mice have failed to identify significant
interconversion of identity between pancreatic compartments
during adult life. In other words, under normal conditions genet-
ically labeled alpha, beta, duct, and acinar cells give rise to, and
are generated from, alpha, beta, duct, and acinar cells only
(Desai et al., 2007; Dor et al., 2004; Herrera, 2000; Kopinke
andMurtaugh, 2010; Solar et al., 2009), obeying tissue dynamics
described by Charles Leblond as ‘‘expanding tissues’’ (Leblond,
1964) or more recently as a ‘‘simple duplication’’ mode of main-
tenance. These findings, therefore, suggested that stem or pro-
genitor cells in the adult pancreas do not exist. This view has
major implications for the future of regenerative therapy in dia-
betes, because the only potential route for the generation of
new beta cells during adult life would thus be replication of differ-
entiated beta cells. In the case of type 1 diabetes, where beta
cells are almost totally eliminated by autoimmune destruction,
transplantation of induced pluripotent stem cells or embryonic
stem cell-derived beta cells would be the only way to a cure.
The absence of stem or progenitor cells and transition of cells
between differentiated compartments also has implications for
the cellular origins of pancreatic cancer: under a ‘‘simple dupli-
cation’’ model, pancreatic ductal adenocarcinoma and its pre-
cursors (pancreatic intraepithelial neoplasia, or PanIN, lesions),
which resemble ducts, are probably derived from ducts. If ducts
were indeed the tissue harboring the cell of origin for pancreatic
cancer, we would need to understand their biology much better
to identify the events that lead to cancer, to search for early diag-
nostic markers, and more.
What remains unaddressed under this framework is whether
facultative progenitor cells exist in the adult pancreas: that is,
whether ‘‘standard’’ terminally differentiated cells under normal
conditions gain progenitor characteristics under specific injury
conditions, as has been shown to occur in the liver when injuredhepatocytes are prevented from entering the cell cycle (Michalo-
poulos, 2011; Shin et al., 2011).
Several lineage tracing studies have examined pancreas cell
dynamics after specific injury conditions, for example partial
pancreatectomy, pancreatic duct ligation, and partial ablation
of beta cells (Dor et al., 2004; Nir et al., 2007; Solar et al.,
2009). By and large, these studies have not found any evidence
for intercompartment transitions. However, proving the negative
is always difficult, so controversy on facultative progenitors in
the pancreas persists.
Recent findings provide solid evidence for the existence of
facultative progenitor cells in the adult pancreas and offer a
view that may reconcile previous contradicting reports. In
2008, Harry Heimberg’s group reported that pancreatic duct
ligation (PDL), a century-old surgical procedure that causes the
degeneration of acinar cells in the ligated part, leads to the
doubling of beta cell mass via the formation of Neurogenin3+
embryonic-like progenitor cells in ducts (Van de Casteele et al.,
2013; Xu et al., 2008). The suggestion that a specific injury to
the exocrine pancreas may trigger the embryonic program of
beta cell formation led to a surge of genetic lineage tracing
studies that directly tested this notion of duct-to-beta-cell
reprogramming. However, these efforts failed to reproduce the
original findings. Increased beta cell mass after PDL was not
seen (Kopp et al., 2011b; Rankin et al., 2013), and genetic label-
ing of pre-existing ducts using multiple different promoters
(Hnf1beta, Hes1, and Sox9) (Kopinke et al., 2011; Kopp et al.,
2011a, 2011b; Solar et al., 2009) failed to detect lineage-labeled
endocrine cells. The exception was a study that used the Car-
bonic Anhydrase II promoter to drive Cre expression for genetic
lineage tracing, where beta cells were found to be labeled after
PDL (Inada et al., 2008). However, in this case Cre-recombinase
was not expressed exclusively in duct cells, so the data were
inconclusive. In retrospect, these studies might have simply
labeled the wrong cells.
A recent study from Chris Wright’s group may have resolved
the puzzle (Pan et al., 2013). This study took advantage of a
model proposed by Zhou and Melton to explain the growth
and branching of the embryonic pancreas (Zhou et al., 2007).Developmental Cell 26, July 15, 2013 ª2013 Elsevier Inc. 3
Figure 1. Acinar Cell Plasticity
After pancreatic duct ligation (PDL), acinar cells can convert to embryonic-type
multipotent progenitor cells, giving rise to acinar cells and duct cells. The latter
may turn on expression of Neurogenin3+ and differentiate into endocrine cells.
In the presence of oncogenic Kras mutations, acinar cells give rise to PanIN
lesions and pancreatic ductal adenocarcinoma. The putative intermediate
step between acinar cells and PanIN lesions is acinar-to-ductal metaplasia
(ADM). The link between embryonic-like multipotent progenitor cells and ADM
remains to be defined.
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based on multipotent progenitor cells residing in the tips of
branches. As these progenitors divide, they leave behind ‘‘trunk’’
cells that give rise to duct cells and endocrine cells, and eventu-
ally these tip progenitors differentiate only into acinar cells at the
ends of ducts. Therefore, differentiated acinar cells represent the
most direct progeny of embryonicmultipotent progenitor cells. In
the new study, differentiated acinar cells in adult mice were
permanently labeled using a gene-replacement allele in which
the tamoxifen-dependent Cre-recombinase protein was intro-
duced into the Ptf1a locus. As expected, under normal condi-
tions, labeling of Rosa26-YFP-positive cells remained within
the acinar compartment in adult mice. Performing the PDL pro-
cedure on these mice revealed a striking sequence of events:
while many pre-existing acinar cells died off, some acquired
the molecular signature of embryonic multipotent progenitor
cells at the tips of branches; these progenitors then gave rise
either to acinar cells or to apparently authentic duct cells that,
similarly to the situation during normal embryonic development,
occasionally expressed Neurogenin3 and became hormone-
producing cells including beta cells. Interestingly, endocrine dif-
ferentiation of acinar cells was amplified by targeted chemical
ablation of pre-existing beta cells, suggesting physiological4 Developmental Cell 26, July 15, 2013 ª2013 Elsevier Inc.regulation of the process. The model emerging is that adult
acinar cells, the direct progeny of embryonic multipotent pro-
genitor cells, retain the potential of their ancestors for self-
renewal, as well as differentiation into ductal and endocrine cells.
Acinar cells, the most abundant cell type in the pancreas and an
extremely specialized secretory cell type, might therefore be the
long-sought-after facultative progenitor of the pancreas.
Notably, a conceptually similar study (Desai et al., 2007) in
which acinar cells were labeled using Elastase-CreER did
not reveal any acinar-to-endocrine reprogramming after PDL.
More work will be required to understand the discrepancy
between the two studies, but a likely explanation is the different
timescales of observation. While Desai et al. have examined
the pancreas up to 24 days after PDL, Pan et al. have observed
acinar-to-endocrine reprogramming at 60 days, but not
30 days, after PDL.
Interestingly, recent findings in the pancreatic cancer field
have suggested that acinar cells are the most likely cellular ori-
gins of PanIN lesions and pancreatic ductal adenocarcinoma.
Using lineage-specific transgenic expression of mutant Kras,
the key oncogenic driver of pancreatic cancer, it was found
that acinar cells are the most vulnerable compartment in the
pancreas for oncogenic transformation, dramatically more so
than duct cells (De La O et al., 2008; Habbe et al., 2008; Kopp
et al., 2012; Maitra and Leach, 2012). The current working model
emphasizes the importance of acinar to ductal metaplasia. In this
process, injured acinar cells, for example under inflammatory
conditions (pancreatitis), transiently adopt the morphology and
gene expression pattern of ductal cells. When combined with a
Kras mutation, these cells have a much-increased chance of
proceeding to form PanIN lesions, a step toward the develop-
ment of frank carcinoma. The exact link between neoplastic
transformation of acinar cells and their injury-driven dedifferenti-
ation to embryonic-like multipotent progenitors remains to be
defined.
Thus, plasticity of acinar cells emerges as a tissue feature that
is important for regeneration of all pancreatic compartments and
that, under the influence of oncogenic signaling, can be diverted
to metaplasia and cancer (Figure 1). It is tempting to offer two
generalizations here. First, facultative progenitors of the adult
pancreas turn out to be the immediate differentiated progeny
of embryonic multipotent progenitors; in other tissues in which
adult progenitor cells are difficult to identify, the prime suspects
might be the most recent progeny of embryonic multipotent pro-
genitor cells. Second, facultative progenitor cells might be the
cellular origins of cancer in other organs as well, reconciling
the contrasting views that cancer originates from tissue stem
cells or from terminally differentiated cells, and linking cancer
to aberrant tissue regeneration.
Islet Cell Plasticity
In parallel to the advances in understanding exocrine pancreas
plasticity, several recent studies have demonstrated that the
identity of pancreatic islet hormone-producing cells is not as
stable as previously thought (Figure 2). A paper from Pedro
Herrera’s group reported that after near-total genetic ablation
of beta cells, adjacent glucagon-expressing alpha cells sponta-
neously acquired features of insulin-producing beta cells, effec-
tively transdifferentiating into beta cells (Thorel et al., 2010). In
Figure 2. Islet Cell Plasticity
Experimental and pathologic conditions causing interconversion between islet
cell types.
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manipulations that enforce islet cell reprogramming while retain-
ing cells in the endocrine lineage. Forced expression of the
transcription factor Pax4 in alpha cells converts these cells into
beta-like cells, though with abnormal physiological responses
(Collombat et al., 2009). In the other direction, deletion of the
maintenance DNAmethyltransferase 1 (Dnmt1) in beta cells con-
verts these cells to alpha cells (Dhawan et al., 2011); deletion of
Pax6 converts adult islet cells to ghrelin-expressing epsilon cells
(which are normally absent from postnatal islets) (Hart et al.,
2013); and deletion of Nkx6.1 can convert early-life beta cells
to somatostatin-expressing delta cells (Schaffer et al., 2013).
Interestingly, forced expression of the key beta cell transcription
factorPdx1 in alpha cells eliminated glucagon expression but did
not convert the cells to beta cells; rather, it generated a stable
population of ‘‘unprogrammed’’ endocrine cells not expressing
any hormone (Yang et al., 2011). It remains to be seen whether
conditions can be found that direct such cells to fully functional
beta cells. Finally, a recent paper from Accili’s group reported
that beta-cell-specific deletion of the transcription factor
Foxo1, when combined with metabolic stress, causes diabetes
and reduction of beta cell mass in adult life. However, lineage
tracing showed that beta cells do not undergo apoptosis in this
case; rather, they get stripped of their beta cell identity in a pro-
cess properly termed dedifferentiation and occasionally there-
after redifferentiate into other hormone-producing cell types
(Talchai et al., 2012). The authors of this paper further suggested
that beta cell failure in type 2 diabetes might involve betacell dedifferentiation, and not losses via beta cell death per se.
This latter idea awaits validation using genetic lineage tracing,
for example in diabetic db/db mice, and other innovative
approaches to demonstrate beta cell dedifferentiation in human
diabetes. Because beta cells remain alive, it would be theoreti-
cally possible to drive them back to their original identity: a
new concept of regenerative therapy for diabetes.
These findings are somewhat reminiscent of observations in
cancers of the endocrine pancreas (pancreatic neuroendocrine
tumors, or PNETs). PNETs contain either nonfunctional endo-
crine cells (maintaining an apparent endocrine cell identity, but
not secreting any identifiable hormone) or functioning endocrine
cells that can secrete any of several bioactive substances.
Secreted substances may include normal islet hormones such
as insulin, hormones characteristic of the fetal pancreas such
as gastrin, or even substances not known to be produced by islet
cells at any stage of development (Klo¨ppel, 2011). Thus, while
beta cells in type 2 diabetes are notorious for not dividing (in dia-
metric opposition to the overgrowth situation in cancer), islet cell
dedifferentiation and the acquisition of new endocrine identity
might represent deep molecular similarities between islet cell
tumors and type 2 diabetes.
Finally, the cell of origin of PNET remains unknown. Deletion of
the tumor suppressor menin in beta cells or alpha cells causes
the formation of insulinomas and glucagonomas (Bertolino
et al., 2003; Crabtree et al., 2003; Lu et al., 2010), supporting
an endocrine origin of PNET (interestingly, deletion of menin in
alpha cells has generated both glucagonomas and insulinomas,
suggesting alpha-to-beta reprogramming during the oncogenic
process [Lu et al., 2010]). However, as discussed above for
ductal adenocarcinoma, mutating oncogenes or tumor suppres-
sors in specific cell types shows their tumorigenic potential, not
the actual origin of naturally arising tumors. Interestingly, it has
been speculated that the PNET may in fact originate in the
exocrine pancreas and not in mature islets (Heitz et al., 1979;
Kamisawa et al., 2002; Vortmeyer et al., 2004). Genetic lineage
tracing studies will be required to examine the provocative
idea that neuroendocrine tumors, in addition to ductal adenocar-
cinoma, originate from dedifferentiation of acinar cells.
Challenges Ahead
Cell of Origin in Pancreatic Ductal Adenocarcinoma
So far, evidence for an acinar origin of pancreatic cancer is indi-
rect, based on forced expression of oncogenic Kras in acinar and
other cell compartments, and documenting their relative sensi-
tivity to transformation. A caveat is that there are many more
acinar cells than ductal cells or centroacinar cells; it is difficult
to take this into account in experiments based on cell-type-
specific ectopic expression of an oncogene. In addition, the
key experiment, yet to be performed, is to generate a tumor in
a manner that is not biased for one compartment or another
(e.g., chemical carcinogenesis, or genetic activation of mutant
Kras in all pancreatic lineages). In such tumors, the challenge
is to identify the cell of origin; in other words, we need to know
the actual, not the possible, cell of origin of cancer. This will
require some technical innovation to independently express
oncogenes and permanently mark a specific lineage. In addi-
tion, extrapolating from mouse models to human cancer is
dangerous. Innovative approaches would be required to identifyDevelopmental Cell 26, July 15, 2013 ª2013 Elsevier Inc. 5
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on stably inherited epigenetic marks.
Determinants of Acinar Cell Identity
PDL causes the death of many acinar cells, with a fraction of the
remaining cells converting to a phenotype similar to embryonic
multipotent progenitors. What triggers this dramatic change of
identity and potential in acinar cells? Are all acinar cells identical
in their potential for such reprogramming? Do human acinar cells
behave similarly? Identifying the factor or factors behind this
phenomenon may take the field from a somewhat arcane surgi-
cal procedure to a new kind of pharmacology.
Biological Significance of Exocrine Pancreas Plasticity
toward the Endocrine Lineage
The recent lineage tracing-based demonstration of beta cells
formed by acinar cell reprogramming via a ductal intermediate
(Pan et al., 2013) is exciting, but many important questions
remain open. For example, does a similar process occur in
humans? Again, innovative approaches would be required to
obtain data at a level of confidence that approaches information
from genetic lineage tracing studies in mice. Second, does
acinar reprogramming have any functional significance, in partic-
ular in diabetes? Quantitatively, the effects documented so far
after PDL appear to be too small to matter for overall organ func-
tion. The issue goes beyond the mere number of beta cells that
are formed: to be therapeutically relevant, acinar-derived beta
cells must be functional in terms of glucose-stimulated insulin
secretion, which remains to be demonstrated. On the positive
side, even if plasticity currently represents aminor event, it might
be possible to harness and enhance this process for treating
diabetes. This extension would require a deep molecular and
physiological understanding of acinar-to-endocrine plasticity,
translated to pharmacologic tools.
Intra-islet Plasticity toward Beta Cells
What controls the decision of an alpha cell to reprogram into a
beta cell? Can other cells perform the same task? Can the pro-
cess be controlled experimentally? Do all endocrine cells have
the potential for conversion? While we still do not fully under-
stand the rules that govern endocrine cell plasticity, the striking
similarity in genome-wide chromatin structure between alpha
and beta cellsmight be the basis for the relative ease of intra-islet
cell transitions (Bramswig et al., 2013). The beta cell ablation
system developed by Herrera and colleagues (Thorel et al.,
2010) provides a good experimental platform to address many
of these questions.
Intra-islet Plasticity from Beta Cells
The view that beta cell identity is a fragile state that can be dis-
rupted by metabolic stress is tantalizing because it suggests
that beta cell dedifferentiation rather than beta cell death might
be the predominant cause of beta cell failure in diabetes (most
likely in type 2 diabetes but perhaps taking place even in type
1 diabetes). If dedifferentiated beta cells (and beta cells that
went further to acquire new endocrine identities) could be
pushed back to their functional mature state, diabetes might
be reversed. It remains to be seen whether such a return journey
can be accomplished. Understanding the determinants of beta
cell identity, dedifferentiation, and—potentially—redifferentia-
tion is a fascinating challenge for the near future.
Finally, the recent findings suggest a speculative unifying view
of the link between adult pancreas plasticity and human disease.6 Developmental Cell 26, July 15, 2013 ª2013 Elsevier Inc.In the case of the exocrine pancreas, is it possible that the same
genes and factors that place acinar cells as facultative progeni-
tors, potentially supporting pancreas regeneration, render these
cells particularly susceptible to oncogenic transformation? In the
case of the endocrine pancreas, is it possible that dedifferentia-
tion is a theme common to both type 2 diabetes and islet cell
tumors?
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